Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both ...
Ocular Therapeutix shares are trading higher Thursday after reports suggested Sanofi is preparing a revised bid for the ...
Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA1Biogen ...
Professionally managed assets in the U.S. hit a record $73.7 trillion, with the retail channel nearing a return to recent ...
Paychex, Inc. demonstrates robust fundamentals and growth, supported by its Paycor acquisition and strong exposure to SMBs.
Retail client channel marketshare briefly surpassed institutional channel marketshare in 2020 and 2021, before declining in ...
Q4 2025 Earnings Call Transcript January 15, 2026 BlackRock, Inc. beats earnings expectations. Reported EPS is $13.16, expectations were $12.24. Operator: Good morning. My name is Jennifer and I will ...
Reported $4.15 billion (YoY growth of +90%) in preliminary* full-year 2025 global product net sales, inclusive of $1.29 billion in fourth quarter sales ...
Reports positive early clinical experience from first and only clinically validated, extracellular protein degraders using ...
Siswa Sekolah Rakyat dipersiapkan untuk menyampaikan pidato bertema perdamaian dunia dalam empat bahasa asing saat peresmian ...
Strong Sephience™ (sepiapterin) launch continues with unaudited Q4 global revenue of $92.5M –– Unaudited 2025 total product and royalty revenue of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback